New Offering

New Offering

Big Pharma Split Corp


Harvest Portfolios Group Inc. (“Harvest”) is pleased to announce that Big Pharma Split Corp. (the “Company”) has filed a preliminary prospectus in respect of an initial public offering (the “Offering”) of preferred shares and class A shares (the “Shares”).

The Company will invest in an initially equally-weighted portfolio (the “Portfolio”) of ten issuers comprised primarily of equity securities selected by Harvest from a universe of pharmaceutical issuers that at the time of investment and immediately following each semi-annual reconstitution and rebalancing:
(i) are listed on a North American exchange; (ii) pay a dividend; and (iii) have options in respect of its equity securities that, in the opinion of Harvest, are sufficiently liquid to permit Harvest to write options in respect of such securities (the “Investable Universe”). The Portfolio will be comprised primarily of the largest (as determined by market capitalization calculated in US$) pharmaceutical issuers in the Investable Universe. In order to seek to generate additional returns, Harvest may write call options each month in respect to some or all of the equity securities in the Portfolio.

The investment objectives for the preferred shares are to provide their holders with fixed cumulative preferential quarterly cash distributions in the amount of $0.125 per preferred share ($0.50 per annum or 5.0% per annum on the $10.00 issue price) until December 31, 2022 (the “Maturity Date”) and to return of the original issue price to holders on the Maturity Date.

The investment objectives for the class A shares are to provide their holders with regular monthly cash distributions targeted to be $0.1031 per class A share ($1.2372 per annum or 8.25% per annum on the $15.00 issue price)and with the opportunity for growth in net asset value per class A share.

Harvest will act as the manager, portfolio manager and promoter of the Company and will provide all administrative services required by the Company.

The syndicate of agents for the Offering is being co-led by BMO Capital Markets, CIBC Capital Markets and Scotiabank and also includes National Bank Financial Inc., Canaccord Genuity Corp., GMP Securities L.P., Raymond James Ltd., Desjardins Securities Inc., Echelon Wealth Partners Inc., Industrial Alliance Securities Inc., Mackie Research Capital Corporation and PI Financial Corp.

For additional information: Please visit, e-mail or call toll free 1-866-998-8298

 Preliminary Prospectus  Eng  Fr  Press Release   September 26, 2017